• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ARYA Sciences Acquisition Corp IV - Class A Ordinary Shares (NQ:ARYD)

6.640 UNCHANGED
Last Price Updated: 3:59 PM EDT, Jul 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 6.640
Bid (Size) 7.500 (1)
Ask (Size) 8.600 (1)
Prev. Close 6.640
Today's Range 6.640 - 6.640
52wk Range N/A - N/A
Shares Outstanding 3,250,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Adagio Medical Announces the Closing of the Business Combination with ARYA IV, Creating a Publicly Traded Company Focused on the Innovative Technologies for Treatment of Cardiac Arrhythmias
July 31, 2024
From Adagio Medical, Inc.
Via Business Wire
News headline image
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider
May 06, 2024
From GENENTA SCIENCE SPA
Via GlobeNewswire

Performance

More News

Read More
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
February 25, 2022
Via Benzinga
News headline image
Gene Therapy Player Amicus Therapeutics Terminates SPAC Merger, Shares Fall ↗
February 24, 2022
Via Benzinga
News headline image
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗
February 24, 2022
Via Benzinga
News headline image
The Week In SPAC News - Sunday, Oct. 3 ↗
October 03, 2021
Via Talk Markets
News headline image
Perceptive Advisors-Backed SPAC To Acquire Amicus's Gene Therapy Business ↗
September 29, 2021
Via Benzinga
News headline image
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug ↗
September 29, 2021
Via Benzinga

Frequently Asked Questions

Is ARYA Sciences Acquisition Corp IV - Class A Ordinary Shares publicly traded?
Yes, ARYA Sciences Acquisition Corp IV - Class A Ordinary Shares is publicly traded.
What exchange does ARYA Sciences Acquisition Corp IV - Class A Ordinary Shares trade on?
ARYA Sciences Acquisition Corp IV - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for ARYA Sciences Acquisition Corp IV - Class A Ordinary Shares?
The ticker symbol for ARYA Sciences Acquisition Corp IV - Class A Ordinary Shares is ARYD on the Nasdaq Stock Market
What is the current price of ARYA Sciences Acquisition Corp IV - Class A Ordinary Shares?
The current price of ARYA Sciences Acquisition Corp IV - Class A Ordinary Shares is 6.640
When was ARYA Sciences Acquisition Corp IV - Class A Ordinary Shares last traded?
The last trade of ARYA Sciences Acquisition Corp IV - Class A Ordinary Shares was at 07/31/24 03:59 PM ET
What is the market capitalization of ARYA Sciences Acquisition Corp IV - Class A Ordinary Shares?
The market capitalization of ARYA Sciences Acquisition Corp IV - Class A Ordinary Shares is 21.58M
How many shares of ARYA Sciences Acquisition Corp IV - Class A Ordinary Shares are outstanding?
ARYA Sciences Acquisition Corp IV - Class A Ordinary Shares has 22M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap